Soreide Law Group recently filed a FINRA arbitration for a customer of Laidlaw & Company for losses in several offerings where the firm is advertising through their website that they were the underwriter of the investments. The offerings at issue are contained in the list below but there are many offerings that that they are the underwriter of that investors may own that may be performing poorly or not performing as promised. Some investments below may not have gone down in value, but many alternative investments in this list have. Here is a list of investments LaidLaw & Company is advertising that they were the underwriter of through their investment banking business.
AirLift Investments, LLC
Private-I Partners, LLC
T-Bird Partners, LLC
Bionic Partners, LLC
Shire Investments, LLC
Bluebird Investment Partners
Pre-Game Partners, LLC
Pre-Flight Partners, LLC
Pre-Market Partners, LLC
Social T Partners, LLC
Face-Off Partners II, LLC
Chain-Link Partners, LLC
Face-Off Partners, LLC
Below is a list of common stock offerings that may or may not have declined in value, but many investors who own these could have other investments that lost money:
MEI Pharma
Eleven Biotherapeutics
AIT Therapeutics
Hoth Therapeutics
Affimed (Affi Med)
Gemphire
Athenex, Inc.
Fennec Pharmaceuticals
Cytori Therapeutics
ADMA Biologics
Onconova Therapeutics
Asterias Biotherapeutics
Flexion Therapeutics
Aldeyra Therapeutics
MabVax Therapeutics, Inc.
Repros Therapeutics
Biosig Technologies
Therapix Biosciences
Alliqua
Actinium Pharmaceuticals, Inc.
Relmada Therapeutics
Boston Therapeutics
Cyclacel Pharmaceuticals
NovaBay Pharmaceuticals
Protea Biosciences Group, Inc.
Cel-Sci Corporation
If you invested in any of the aforementioned investments call the securities lawyers at Soreide Law Group for a free consultation to see if you may have a potential claims against Laidlaw & Company for selling unsuitable investments. Call (888) 760-6552.
Soreide Law Group is reviewing potential claims from investors who may have been misled or misadvised by securities brokers and financial professionals. One investment under scrutiny is the Shopoff DLV QOZ Fund LLC, a private placement marketed as part of the Qualified Opportunity Zone program. Recent reports reveal troubling developments that investors should be aware […]
Soreide Law Group is currently reviewing potential claims from investors regarding questionable sales practices by securities brokers and financial advisors. One product under scrutiny is SHADOWGLEN DST, a real estate–focused investment vehicle that has drawn attention due to troubling reports and investor risks. Recent information suggests there may be significant concerns about how this product […]
Soreide Law Group is investigating potential investor claims involving sales practice violations by securities brokers and financial advisors connected to ROCKLAND DST. This investment has been promoted as a private placement real estate vehicle, but concerning information has emerged that may affect investors. Below we outline what ROCKLAND DST is, the issues surrounding it, and […]
Phone:
Fax: 1-954-760-6553
Email: info@securitieslawyer.com